Investigation of SIRT4 in this context could also be valuable as reduced levels of this sirtuin have been demonstrated in patients with NAFLD (19) and it has been proposed that this may be a driver of increased ROS production in this disease. This evidence concerns the gene SIRT4 and metabolic dysfunction-associated steatotic liver disease.